We are live on ! Find out more
ADXN

Addex Therapeutics
ADXN

1 hedge funds and large institutions have $115K invested in Addex Therapeutics in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CC
Caxton Corporation
New Jersey
+$152K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1
Caxton Corporation
New Jersey
$115K +$152K +871 New

ADXN Hedge Fund Activity: Q1 2020 in Review

1 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Addex Therapeutics (ADXN) for Q1 2020, worth a combined $115K.

Buyers outnumbered sellers: 1 fund opened new ADXN positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Caxton Corporation, opening a new position worth an estimated $152K.

  • 1 institutional investor held Addex Therapeutics (ADXN) as of Q1 2020, up from 0 in Q4 2019.
  • Funds reported $115K of Addex Therapeutics stock for Q1 2020.
  • 1 fund opened new Addex Therapeutics positions in Q1 2020 and 0 closed out, a net change of +1 holder.
  • The largest Addex Therapeutics buyer in Q1 2020 was Caxton Corporation, an estimated $152K added.

Based on aggregated 13F filings for Q1 2020.